Efektivnost obuka izvršilaca u sistemu menadžmenta kvaliteta u medicinskoj i farmaceutskoj industriji
##plugins.themes.bootstrap3.article.main##
Apstrakt
Efektivnost obuka izvršilaca predstavlja jedan od ključnih elemenata uspešnog funkcionisanja sistema menadžmenta kvaliteta u medicinskoj i farmaceutskoj industriji, naročito u kontekstu zahteva standarda ISO 13485 i dobre dokumentacione prakse (GDP). Ovaj rad bavi se analizom značaja i efektivnosti obuka zaposlenih, sa posebnim fokusom na primenu GDP principa i ALCOA koncepta u cilju obezbeđivanja integriteta podataka.
U radu su razmatrani relevantni zahtevi standarda ISO 13485, kao i primer iz prakse koji ukazuje na posledice neadekvatne obučenosti zaposlenih u oblasti upravljanja dokumentacijom. Primenom Ishikawa metode identifikovani su uzroci neusaglašenosti, dok je analiza CAPA procesa ukazala na ograničenja postojećih mehanizama za unapređenje kvaliteta.
Rezultati pokazuju da formalno sprovedene obuke ne garantuju njihovu efektivnu primenu u praksi, već je neophodan sistemski pristup koji obuhvata kontinuirano praćenje, evaluaciju i unapređenje programa obuka. Zaključuje se da adekvatno planirane i sprovedene obuke značajno doprinose smanjenju rizika, unapređenju usaglašenosti i jačanju sistema menadžmenta kvaliteta.
##plugins.themes.bootstrap3.article.details##
Reference
[2] Antola, G., Procedure improvement for designing and developing medical devices in compli-ance with MDR and ISO 13485: Case study on osteotomy plates series, M.Sc. thesis, Politecni-co di Torino, Italy, 2024.
[3] Beydoun, A. R., Saleh, R.F., Literature review on training and development in work setting, BAU Journal – Society, Culture and Human Behavior, 4 (2023), 2, Article 13.
[4] Cao, Y., Umberger, G., Shelton, A., Butts, T., Development of a supplier scorecard for a medical device company toward ISO 13485:2016, Journal of Pharmaceutical Innovation, 2022.
[5] ***, EudraLex – Volume 4: EU guidelines for good manufacturing practice, European Commission, Brussels, Belgium, 2022.
[6] Filipović, J., Đurić, M., Ruso, J., Sistem menadžmenta kvaliteta, Fakultet organizacionih nauka, Beograd, Srbija, 2018.
[7] ***, Menadžment i organizacija: Priručnik za pripremu prijemnog ispita, Fakultet organizacio-nih nauka, Beograd, Srbija, 2024.
[8] Geremia, F., Quality aspects for medical devices, Microchemical Journal, 2018.
[9] Hrgarek, N., Bowers, K.-A., Integrating Six Sigma into a quality management systems, Jour-nal of Information and Organizational Sciences, 33 (2009), 1, pp. 1-12.
[10] ***, ICH guideline Q9 (R1): Quality risk management, European Medicines Agency, 2023.
[11] ***, ISO 9001:2015 Quality management systems – Requirements, ISO, Geneva, Switzerland, 2015.
[12] ***, ISO 13485:2016 Medical devices - Quality management systems, ISO, Geneva, Switzer-land, 2016.
[13] Ishikawa, K., Guide to quality control, Asian Productivity Organization, Tokyo, Japan, 1986.
[14] Juran, J. M., Godfrey, A. B., Juran’s quality handbook, McGraw-Hill, New York, USA, 1999.
[15] Kortelainen, T. M., Milovanov, M. A., The role of ISO 9001 and ISO 13485 quality mana-gement systems, M.Sc. thesis, University of Eastern Finland, 2025.
[16] Martin, J., Elg, M., Gremyr, I., Wallo, A., Quality management competence framework, Total Quality Management & Business Excellence, 2019.
[17] ***, GxP data integrity guidance and definitions, MHRA, London, UK, 2018.
[18] Oakland, J. S., Total quality management and operational excellence, Routledge, London, UK, 2014.
[19] Reason, J., Human error: Models and management, BMJ, 320 (2000), pp. 768-770.
[20] Sakdiyah, S. H., Eltivia, N., Afandi, A., Root cause analysis using fishbone diagram, Journal of Applied Business, Taxation and Economics Research, 1 (2022), 6, pp. 566-576.
[21] Soković, M., Pavletić, D., Kern Pipan, K., Quality improvement methodologies, Journal of Achievements in Materials and Manufacturing Engineering, 43 (2010), 1, pp. 476-483.
[22] ***, Guidance for industry: Quality systems approach to CGMP regulations, U.S. Food and Drug Administration, 2006.
[23] ***, Process Validation: General Principles and Practices, U.S. Food and Drug Administrati-on, 2011.
[24] ***, Guidance on good data and record management practices, World Health Organization, Geneva, Switzerland, 2016.
http://orcid.org/0009-0002-6447-7572
